Established in March 1996, Seodong Medical is a specialized medical device company for dry eye treatment that is loved not only domestically but also internationally as a company of trust and reliability with a long history of 28 years. NURIEYE-5800 is a dry eye treatment medical device that has been approved for clinical trials by the government and has been verified for safety and effectiveness through clinical trials on 144 dry eye patients at two government-designated university general hospital clinical trial centers. The NURIEYE-5800 paper was published in the January 2014 issue of the British Journal of Opthalmology, a British SCI journal, and the safety and effectiveness evaluation results of the new medical technology were announced in November 2014, and has been available in eye hospitals nationwide since July 2016. We are doing paid treatment.
moreEXHIBIT
NURIEYEPREMIUM
trust with a long history of 28 years, and is a company specializing in dry eye treatment medical devices that is loved not only domestically but also overseas. NURIEYE-5800 is a dry eye treatment medical device that has been approved for clinical trials by the government and has been verified for safety and effectiveness through clinical trials on 144 dry eye patients at two government-designated university general hospital clinical trial centers.
More
COMPANY INTRODUCTION
Established in March 1996, Seodong Medical is a specialized medical device company for dry eye treatment that is loved not only domestically but also internationally as a company of trust and reliability with a long history of 28 years. NURIEYE-5800 is a dry eye treatment medical device that has been approved for clinical trials by the government and has been verified for safety and effectiveness through clinical trials on 144 dry eye patients at two government-designated university general hospital clinical trial centers. The NURIEYE-5800 paper was published in the January 2014 issue of the British Journal of Opthalmology, a British SCI journal, and the safety and effectiveness evaluation results of the new medical technology were announced in November 2014, and has been available in eye hospitals nationwide since July 2016. We are doing paid treatment.
